789 results on '"Borrow, R"'
Search Results
2. Influence of Age and Carriage Status on Salivary IgA to Neisseria meningitidis
3. Genetic Analysis of Capsular Status of Meningococcal Carrier Isolates
4. Improved Methods of Detection of Meningococcal DNA from Oropharyngeal Swabs from Cases and Contacts of Meningococcal Disease
5. Induction of Immunological Memory in UK Infants by a Meningococcal A/C Conjugate Vaccine
6. Salivary Antibodies Following Parenteral Immunization of Infants with a Meningococcal Serogroup A and C Conjugated Vaccine
7. Epidemiological Characterization of Methicillin-Resistant Staphylococcus aureus Isolated in the North West of England by Protein A (spa) and Coagulase (coa) Gene Polymorphisms
8. Acquisition and Carriage of Meningococci in Marine Commando Recruits
9. Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
10. Non-Culture Diagnosis and Serogroup Determination of Meningococcal B and C Infection by a Sialyltransferase (SiaD) PCR ELISA
11. Global Meningococcal Initiative : guidelines for diagnosis and confirmation of invasive meningococcal disease
12. Variations in Neisseria meningitidis carriage by socioeconomic status : a cross-sectional study
13. The role of outer membrane proteins and lipooligosaccharide in the immunogenicity and pathogenicity of Neisseria meningitidis
14. Serum bactericidal antibody assays – The role of complement in infection and immunity
15. MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children
16. What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience
17. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms – A pilot study
18. Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
19. Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.
20. Haemophilus influenzae serotype b seroprevalence in central Lao PDR before and after vaccine introduction.
21. Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary-School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial
22. Seroprotection against Serogroup C Meningococcal Disease in Adolescents in the United Kingdom: Observational Study
23. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020
24. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: An international vaccine-recipient survey
25. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010–2017)
26. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010–2017)
27. Invasive meningococcal disease: Timing and cause of death in England, 2008–2015
28. Variation by lineage in serum antibody responses to influenza B virus infections
29. Inmunogenicidad e inducción de memoria inmunológica de la vacuna antineumocócica conjugada heptavalente en lactantes prematuros del Reino Unido
30. Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
31. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine
32. Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case–control study and a systematic review
33. A cluster of four cases of meningococcal disease in a single nuclear family
34. Chronic respiratory diseases impact pneumococcal antibody levels and response to pneumococcal vaccine.: P. 62
35. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
36. Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults
37. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis
38. Genomic characterization of novel Neisseria species
39. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015
40. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
41. Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt
42. Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin
43. Influence of age and carriage status on salivary IgA to Neisseria meningitides
44. Role of gene polymorphisms of interleukin-10 and CD14 in meningococcal disease: P1854
45. DT5aP-Hib-IPV and MCC vaccines: preterm infants’ response to accelerated immunisation
46. The Serogroup B Meningococcal Vaccine Bexsero Elicits Antibodies to Neisseria gonorrhoeae
47. Design and evaluation of a CustomSeq microarray for genotypic characterisation of Neisseria meningitides
48. Measurement and interpretation of pneumococcal IgG levels for clinical management
49. Assessing immune responses to pneumococcal vaccines
50. Impact of meningococcal C conjugate vaccine in the UK
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.